
Electronic deprescribing prompts nearly tripled medication cutbacks in long-term care
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
In a cluster randomized trial, attaching individualized electronic deprescribing reports to routine medication reviews nearly tripled how often long-term care residents had medications stopped.
What NurseJet pulled from the source
This stepped-wedge cluster randomized trial across five long-term care homes enrolled 725 residents (median age 84), each on a median of 10 medications and 3 potentially inappropriate ones. Attaching prioritized, resident-specific electronic deprescribing reports to the quarterly medication reviews already in place raised the share of residents who had a medication deprescribed from 12.7% under usual care to 36.4% (adjusted odds ratio 1.58; 95% CI 1.07 to 2.34).
Why this matters for nurses
Polypharmacy is the daily reality in long-term care, where the study notes up to 88% of residents face potentially inappropriate prescribing. This may matter because better-targeted prompts attached to a review you already attend can meaningfully increase how often risky medications actually get stopped, reinforcing that the periodic medication review is a real chance to raise specific drugs for reassessment.
Bedside takeaway
Worth knowing that attaching individualized electronic deprescribing reports to the routine quarterly medication reviews nearly tripled how often long-term care residents had a medication stopped.
Explain this for my unit
Key takeaways
- Residents took a median of 10 medications and 3 potentially inappropriate medications each.
- Deprescribing rose from 12.7% under usual care to 36.4% with individualized electronic reports (AOR 1.58; 95% CI 1.07 to 2.34).
- The reports were attached to existing quarterly medication reviews rather than adding a separate process.
- The population was old and frail (median age 84), the group most exposed to medication harm.
Practice implications
- Treat the periodic medication review as a concrete chance to surface specific drugs for the prescriber to reassess, and know which residents are on high medication counts and flagged inappropriate medications. When a report or pharmacy review names a candidate, follow through with the prescriber, and after any medication is stopped keep monitoring for withdrawal effects or return of symptoms.
Limitations & cautions
- The trial was cluster randomized across only five homes in one Canadian province, so results may not generalize. The abstract reports the deprescribing rate but not safety outcomes such as adverse withdrawal events, falls, or hospitalizations, so the net clinical benefit and harms are not established here.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
JAMA Network Open (PubMed)
JAMA Network Open (PubMed). Electronic Decision Support for Deprescribing in Older Adults Living in Long-Term Care: A Stepped-Wedge Cluster Randomized Trial.
https://pubmed.ncbi.nlm.nih.gov/40445620/
Professional education only


